CompaniesOriel Therapeutics

Oriel Therapeutics

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

879

By Phase

PHASE1: 1

By Status

COMPLETED: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2013
2014
2015
2016
Today
NCT02260492
Hover over trial bars to see details

Recent Trials

NCT02260492Lead Sponsor
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
PHASE1Completed
879 participants
Started: Sep 30, 2014 · Completed: Jul 31, 2015